Marc d'Abbadie
Direktor/Vorstandsmitglied bei Spark Nw Carry Partner LLP
Profil
Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd.
He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd.
Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd.
He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.
Aktive Positionen von Marc d'Abbadie
Unternehmen | Position | Beginn |
---|---|---|
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | Private Equity Investor | - |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Direktor/Vorstandsmitglied | - |
Spark Nw Carry Partner LLP | Direktor/Vorstandsmitglied | - |
Nwf4b Directors Ltd. | Direktor/Vorstandsmitglied | - |
Dadu Investments Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marc d'Abbadie
Unternehmen | Position | Ende |
---|---|---|
THERACRYF PLC | Direktor/Vorstandsmitglied | 08.11.2018 |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services EnXray Ltd. operates as a medical technology company. Its technology includes low energy x-rays, radiation sterilization and lexr benefits. The company was founded by Edward cappabianca in 2012 and is headquartered in Liverpool, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | - |
░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Marc d'Abbadie
Trinity College, Cambridge | Graduate Degree |
University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
THERACRYF PLC | Health Services |
Private Unternehmen | 10 |
---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
SPARK Impact Ltd.
SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | Finance |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Health Technology |
Spark Nw Carry Partner LLP | |
Nwf4b Directors Ltd. | |
Dadu Investments Ltd. | |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Health Technology |
EnXray Ltd.
EnXray Ltd. Information Technology ServicesTechnology Services EnXray Ltd. operates as a medical technology company. Its technology includes low energy x-rays, radiation sterilization and lexr benefits. The company was founded by Edward cappabianca in 2012 and is headquartered in Liverpool, the United Kingdom. | Technology Services |